Private equity firm CDC Group has dedicated USD 40 million to funds in south-east and central Asia. USD 30 million has been slated for the Kendall Court Mezzanine (Asia) Bristol Fund, while USD 10 million will go to Centras Private Equity Fund. Both funds will be targeting small and medium sized enterprises in their specific geographic regions; Kendall in south-east Asia and Centras in central Asia.
Centras Private Equity Fund
The European Bank for Reconstruction and Development (EBRD) established the Centras Private Equity Fund near the end of 2006. It was formed as a private limited company incorporated under the laws of Guernsey, with General Partner Centras Securities being appointed as investment manager. The fund seeks to raise a total of USD 75 million to invest primarily in the Republic of Kazakhstan.
Kendall Court Capital Partners Ltd.
Founded in 2004 as Kendall Court Capital Partners Ltd., the firm’s initial fund was valued at USD 90 million. As of the end of 2006 Kendall had USD 150 million of funds under management primarily in south-east Asia. With this new round of funding the company has set a target of USD 150 million for additional investments, concentrating on mezzanine growth capital and buyout capital deals.
CDC Group (www.cdcgroup.com)
CDC is a fund of funds owned by the government of the UK. It was founded in 1948 with the goal of providing business financing in the former UK colonies. Through the years CDC has evolved to what it is today, a fund with net assets of USD 4 billion. The firm invests mainly in private equity funds doing business in Asia, Africa and Latin America. Currently CDC is concentrating it activity in southern Asia and sub-Saharan Africa.
26/01/2009
Central & Eastern Europe, Financial Services, Kazakhstan, Private Equity News